Ambulatory Oxygen for Pulmonary Fibrosis (OxyPuF): a randomised controlled trial and acceptability study
This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number NIHR131149.
Authors
- Alisha Maher (ORCID: https://orcid.org/0000-0002-9738-2935)
- Nicola Gale (ORCID: https://orcid.org/0000-0001-5295-8841)
- Rachel Adams (ORCID: https://orcid.org/0000-0002-1798-3854)
- David Thickett (ORCID: https://orcid.org/0000-0002-5456-6080)
- Alice Margaret Turner (ORCID: https://orcid.org/0000-0002-5947-3254)
- Anjali Crawshaw (ORCID: https://orcid.org/0000-0001-7304-6374)
Institutions
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Cancer Research UK Clinical Trials Unit (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- Health Technology Assessment
- Published
- 2025-07-01
- DOI
- https://doi.org/10.3310/twks4194
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Health Technology Assessment Programme